Richard Sykes - Jun 24, 2024 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Stock symbol
PDSB
Transactions as of
Jun 24, 2024
Transactions value $
$0
Form type
4
Date filed
6/25/2024, 04:05 PM
Previous filing
Jul 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Employee Stock Option (Right to Buy) Award $0 +9K $0.00 9K Jun 24, 2024 Common Stock 9K $2.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.